In conclusion, NCT03454893 was an open-label clinical study aimed at assessing the autologous transplantation of CD34+ stem cells that were modified with a lentiviral vector carrying the human GLA gene in 15 patients diagnosed with Fabry disease (FD). This evidence concerns the gene GLA and Fabry disease.